Issues on optimization of primary health care for working patients with diagnosed hypertension
Year: 2017, volume 13 Issue: №1 Pages: 007-009
Heading: Health Service Organization Article type: Original article
Authors: Shulpina N.Yu., Erugina M.V, Sazanova G.Yu, Krom I.L.
Organization: Saratov State Medical University
Heading: Health Service Organization Article type: Original article
Authors: Shulpina N.Yu., Erugina M.V, Sazanova G.Yu, Krom I.L.
Organization: Saratov State Medical University
Summary:
Aim: to justify the ways of optimization of availability of primary health care for working-age patients with arterial hypertension. Material and Methods. The study of the availability of drug treatment of working-age patients with arterial hypertension was based on a survey of 409 patients and calculated the average cost of treatment of this group of patients for 1 month in accordance with the care standards. Results. On 01.06.2016, the cost of treatment for a patient with stage 1 hypertension amounted to 316.89 rubles per month, with 2 stage 652.68 rubles per month. 67% of patients of working age are unable to follow the doctor's recommendations and take the prescribed medicines. Conclusion. Provision of free medicines to patients with arterial hypertension of stages 1 and 2 and the formation of their commitment to preventive treatment causes a direct economic effect, which will be 7915979 rubles per year, and indirect economic effect of the decreased mortality from cardiovascular diseases, disability, reduce in disability days and increase of the gross domestic product.
Bibliography:
1. Kalininskaya AA, Son IM. The Model of reforming primary health care. Healthcare of the Russian Federation 2008; 5: 6-10
2. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual datafor one million adults in 61 prospective studies. Lancet 2002; 360: 1903-1913
3. Reshetnikov AV. The Medical sociological monitoring: a Guide. M.: Medicine, 2003; 1048 p.
4. Chazova IE, Ratova LG, Boycov SA, Nebieridze DB. Recommendations for the management of arterial hypertension Russian Medical Society of Arterial Hypertension and Society of Cardiology of the Russian Federation. Systemic hypertension 2010; (3): 5-26
5. Svishchenko ЕР, Yarynkina ЕА. The Prevention of stroke and vascular dementia in hypertensive patients: the value of blockers of receptors of angiotensin II. Hypertension 2010; 2 (10): 71-75
6. Hohlov AL, Lisenkova LA, Rakov AA. Analysis of the determinants of adherence to antihypertensive therapy. Good clinical practice 2003; 4: 59-66
7. Neutel JM, Smithy Н. Improving patient compliance: a major goal in the management of hypertension. Clin Hypertens 2003; 5 (2): 127-32
8. Simpson SH, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333(7557): 15
9. Lawes CMM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease. Lancet 2001; 371: 1513-8
10. Gorgui J, Gorshkov M, Khan N, et al. Hypertension as a risk factor for ischemic stroke in women. The Canadian journal of cardiology 2014; 30 (7): 774-82
11. Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 2016; 387 (10017): 435-43
12. Ettehad D, Emdin C, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387 (10022): 957-6.
| Attachment | Size |
|---|---|
| 2017_01_007-009.pdf | 268.76 KB |
Русский
English